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ABSTRACT
We investigated a relationship between the FLAIR signal found in mesial temporal 
sclerosis (MTS) and inflammation. Twenty nine patients were selected through clinical and 
MRI analysis and submitted to cortico-amygdalo-hippocampectomy to seizure control. 
Glutamate, TNFα, IL1, nitric oxide (NO) levels and immunostaining against IL1β and CD45 
was performed. Control tissues (n=10) were obtained after autopsy of patients without 
neurological disorders. The glutamate was decreased in the temporal lobe epilepsy (TLE) 
-MTS group (p<0.001), suggesting increased release of this neurotransmitter. The IL1β and 
TNFα were increased in the hippocampus (p<0.05) demonstrating an active inflammatory 
process. A positive linear correlation between FLAIR signal and NO and IL1β levels and a 
negative linear correlation between FLAIR signal and glutamate concentration was found. 
Lymphocytes infiltrates were present in hippocampi of TLE patients. These data showed 
an association between hippocampal signal alteration and increased inflammatory markers 
in TLE-MTS.
Key words: FLAIR hippocampal signal, cytokines, NO, glutamate and hippocampal 
sclerosis.
Correlação da intensidade do sinal em FLAIR e os níveis de mediadores inflamatórios 
no hipocampo de pacientes com epilepsia do lobo temporal e esclerose mesial 
temporal
RESUMO
Este estudo foi delineado para investigar a presença de relação entre a intensidade de sinal 
em FLAIR e níveis de citocinas, óxido nítrico (NO) e glutamato no hipocampo de pacientes 
com epilepsia do lobo temporal refratária, associada com esclerose mesial (TLE-MTS). Vinte 
e nove pacientes foram selecionados através de análise clínica e de ressonância magnética 
(RM) que foram submetidos a cortico-amigdalo-hipocampectomia para o controle das 
crises. Os níveis de glutamato foram avaliados por HPLC, as citocinas TNFα e IL1β por 
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ELISA e os níveis de NO via NO system. Avaliamos também por imuno-histoquímica a 
expressão de IL1β e CD45 em tecidos controles e com esclerose. Tecido controle foi obtido 
após autópsia de indivíduos mortos sem disfunções inflamatórias e neurológicas (n=10). A 
concentração de glutamato se mostrou reduzida no tecido TLE-MTS (p<0,001) sugerindo 
aumento na liberação desse neurotransmissor. TNFα e IL1β também apresentaram níveis 
elevados no hipocampo dos pacientes (p<0,05), demonstrando um processo inflamatório 
crônico. Houve uma correlação linear positiva entre a intensidade do sinal em FLAIR e os 
níveis de NO e IL1β. Em contraste, uma correlação linear negativa foi encontrada entre 
a intensidade do sinal em FLAIR e níveis de glutamato no hipocampo com esclerose. 
Infiltrado linfocitário hipocampal também foi visualizado pela imuno-marcação com CD45 
em pacientes com TLE-MTS. Esses dados mostraram uma associação entre alteração de 
sinal na RM e marcadores inflamatórios em pacientes com TLE-MTS.
Palavras-chave: sinal hipocampal em FLAIR, citocinas, NO, glutamato, esclerose 
hipocampal.
Temporal lobe epilepsy (TLE) represents a severe 
common syndrome in patients presenting refractory sei-
zures. Atrophy and/or signal changes of the hippocampus 
have been described as the most reliable magnetic reso-
nance imaging (MRI) inclusion criteria in mesial temporal 
sclerosis (MTS). These alterations are the most frequent 
pathological findings presented by these patients1. In ad-
dition ipsilateral temporal pole signal and volume abnor-
malities are described as part of the spectrum of MRI fea-
tures in cases of MTS2. The hippocampal sclerosis (HS) is 
also known as Ammon’s horn sclerosis and includes se-
lective hippocampal cell loss, gliosis and synaptic reor-
ganization as the mossy fibers sprouting3,4. Indeed, HS is 
seen as loss of volume, decreased T1 and increased T2 
signals on views through the structure, associated with 
ipsilateral temporal lobe atrophy and significant asymme-
try of hippocampal volume5,6. The predominant cell loss 
occurs in pyramidal neurons of the stratum pyramidale 
of Ammon’s horn. Neuronal population of the stratum 
oriens survives in most sclerotic hippocampi, along with 
interneurons scattered throughout the neuron-depleted 
pyramidal layer. In the dentate gyrus, many of the gran-
ule cells are lost and neurons in the granule cell layer ap-
pear to be more dispersed. Thus, several lines of evidence 
point to sclerotic hippocampus as the major structure in-
volved in chronic seizures observed in MTS, for review, 
see7. As reported by Bernasconi et al.8 the hippocampal 
head is more atrophic than hippocampal body and tail, 
between other structures also involved such as amygda-
la, entorhinal and perihinal cortices.
The immune system and associated inflammatory 
process play important function in the protection and 
repair of several tissues, thus constituting an adaptive, 
beneficial endogenous response. In contrast, immune re-
sponse activation can also be a direct or indirect cause of 
neuronal dysfunctions. During inflammatory process the 
communication between cells of the immune system oc-
curs either via direct cell-to-cell contact or via soluble fac-
tors called cytokines such as IL1β, IL6 and TNFα9. Dele-
terious effects of cytokines on neuronal survival are like-
ly to be mediated by their ability to provoke an extracel-
lular increase of glutamate by acting on the mechanisms 
of its release and reuptake, potentiating the function of 
ionotropic glutamate receptors10, enhancing the produc-
tion of mediators of oxidative stress11. 
In the same direction, nitric oxide (NO) production 
increases in neurodegenerative diseases as consequence 
of oxidative stress. NO synthesis is activated in cerebral 
diseases by the release of glutamate combined with inhi-
bition of glutamate removal, which leads to N-methyl-D-
aspartate (NMDA) receptor over activation and excess 
Ca++ influx into neurons12. It is believed that the toxic ef-
fect of NO results from the action of its downstream me-
tabolite, ONOO-, which is a highly reactive, formed when 
NO reacts with superoxide radicals, which also regulate 
excitotoxicity and induce oxidative DNA, damage13. Exci-
totoxicity due excessive glutamate receptors activation is 
also associated with osmotic imbalance, when countered 
by an influx of Na+, Cl– and water. This situation conduc-
es to cell edema with eventual plasma membrane rupture 
and cell death12,14-16.
In this context, the present work was delineated to 
study a possible correlation between the alteration of the 
signal in the head, body and tail of the hippocampus ob-
tained after fluid-attenuated inversion-recovery (FLAIR) 
MRI analysis and the levels of IL1β, TNFα, glutamate and 
NO in patients with TLE and MTS submitted to corti-
co-amygdalo-hippocampectomy to seizure control. Thus, 
we hypothesize that the inflammatory process associated 
with excitotoxicity in the hippocampus could be respon-
sible for the alteration of signal found in MRI analysis of 
patients with TLE 
In this work we also investigated a possible involve-
ment of both hemispheres in TLE associated to MTS an-
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alyzing the intensity of the ipsilateral signal (hippocam-
pal sclerosis) versus the contralateral signal, from each 
patient. The relationship between the levels of IL1β, 
TNFα, glutamate and NO with the type of sclerosis us-
ing Blumcke citeria17 was also investigated. Furthermore, 
immuno-histochemistry against IL1β, TNFα and CD45 in 
autopsy/control and sclerotic tissues was also performed 
to localize and identify cellular and humoral components 
of immune system.
METHOD
All experiments were performed under approval from 
the Institutional Ethics Committee of the Universidade 
Federal de São Paulo (UNIFESP). Surgical specimens 
from patients with intractable epilepsy were submitted 
to standard cortico-amygdalo-hippocampectomy at the 
Hospital São Paulo (UNIPETE/SPDM-UNIFESP-EPM, 
Brazil). All cases showing neoplasm, vascular malforma-
tions, post-traumatic and ischemic lesions on preopera-
tive MRI were excluded. Selected patients (n=29) had de-
tailed anamnesis, video-EEG recordings and MRI stud-
ies and after these procedures the epileptogenic zone was 
delineated. The age of the patients with TLE and HS var-
ied from 19 to 56 years (36.9±9 years) and this group was 
composed by 72.4% of women and 27.6 % of men. 
The drugs used by these patients for seizure control 
include: carbamazepine, phenobarbital, diphenylhydanto-
in, clobazam, valproate and topiramate. Control hippo-
campi were obtained from brains showing no evidence 
of pathology on the basis of gross and routine histolog-
ical examination removed from autopsies (less than 6h 
of postmortem period). The age of the subjects at death 
varied from 38 to 84 years (67±12 years) (n=10). This last 
group was also composed by 60% of women and 40% of 
men (autopsy/control). 
Thus, the levels of IL1β, TNFα, glutamate and NO 
were measured in the head of hippocampi and correlat-
ed with the FLAIR MRI signal, obtained in the head, body 
and tail of this structure. We also compared IL1β, TNFα, 
glutamate concentration in the hippocampi of patients 
with HS with those found in control tissues, in similar 
hippocampal areas, removed during the autopsy of pa-
tients, without neurological disease (autopsy/control). We 
did not compare NO levels from autopsy/control tissue 
and those obtained from hippocampi of our patients since 
autopsy tissue is not an appropriate control. The post-
mortem levels of NO increases after death due to poly-
amines production and anoxia14,15 and several works have 
reported arterial synthesis of NO after death16. 
The autopsies were made by a pathologist from Path-
ological Anatomic Department Incor, FMUSP, especially 
trained for this purpose. Thus, the pathologist was able to 
remove the same structures as performed by the neuro-
surgeon. Using this procedure, similar hippocampal areas 
from epileptic patients and autopsied subjects could be 
compared. All patients and families had signed the con-
sent term authorizing the tissues utilization. 
MRI acquisition
Patients with clinical diagnostic of TLE and con-
trol subjects were underwent imaging with a 1.5-T Gy-
roscan (Philips Medical System, Eindhoven, The Neth-
erlands) using a standard head coil. The protocol includ-
ed the following: sagittal T1-weighted (repetition time 
[TR]=433 milliseconds, echo time [TE]=13 milliseconds, 
field of view [FOV]=25 cm, 6 mm slice thickness, matrix 
size=256×512); axial turbo-spin echo FLAIR-weighted 
(TR=4535 milliseconds, TE=100 milliseconds, FOV=23 
cm, 6 mm slice thickness, matrix size=256×512); axial 
gradient-echo FLAIR*-weighted (TR=707 milliseconds, 
TE=23 milliseconds, flip angle of 15º, FOV=23 cm, 6 mm 
slice thickness, matrix size=205×256); inversion recov-
ery (IR) T1-weighted (TR=5620 milliseconds, TE=17 mil-
liseconds, inversion time TI=400 milliseconds) and flu-
id attenuated inversion recovery (FLAIR) (TR=8000 mil-
liseconds, TE=150 milliseconds, TI=2350 milliseconds) 
with the same section thickness, FOV and matrix (3 mm, 
23 cm, 256×512) in the coronal planes perpendicular to 
the long axis of hippocampus, including the totality of the 
temporal lobe; fast field echo (FFE) T1-weighted (TR=30 
milliseconds), TE=4.6 milliseconds, one acquisition aver-
age pulse sequence, flip angle=45º, FOV=23 cm, 1.5 mm 
slice thickness with no gaps, matrix size=228×512, in the 
coronal plane. The control group underwent only the cor-
onal FLAIR and FFE T1-weighted sequences.
MRI quantitative analysis – Three FLAIR (20% gap, 
3 mm thickness) slices including hippocampal head, body 
and tail on the coronal plane (perpendicular to the hip-
pocampal axis) were taken from both groups. Hipocam-
pal signal was accessed using Leonardo, Syngo MR 2004A 
(Siemens Medical Solutions, Erlangen, Germany). The 
signal was also measured using the same procedure in 
the pons of each patient, from both groups. This pro-
cedure was done to “normalize” variations between sig-
nals in different MRI as internal standard. Thus, final sig-
nal from hippocampal head, body and tail was ever con-
sidered as the ratio between its proper signals and those 
obtained from the pons of the same subject. All hippo-
campal and pons delimitations were made by the same 
neuroradiologist.
Glutamate quantification
The hippocampi were immediately removed and kept 
in a cryogenic vial, frozen in liquid hydrogen and stored 
at –80ºC, and then weighted. The high performance liq-
uid chromatography (HPLC) was performed using the 
Arq Neuropsiquiatr 2011;69(1)
94
FLAIR: temporal epilepsy 
Varella et al.
method described by Cavalheiro18 with few modifications 
as follow: tissue was ultrasonically homogenized in a per-
chloric acid 0.1 M, 0.02% sodium disulfide and homoser-
ine 10 mg/ml solution (as internal standard). The homog-
enate was done in a proportion of 15 μL solution for each 
milligram of wet tissue. The samples were kept at 0ºC 
overnight and then centrifuged at 11.000 g at 4ºC for 50 
min. The supernatant was filtered and submitted to a re-
action with O-phthaldialdehyde (OPA) and then injected 
into HPLC systems. Amino acid reaction was done dis-
solving 27 mg of OPA in 1mL of methanol, adding 5 µL 
of 2-mercaptoetanol and 9 mL of sodium tetraborate 0.1 
M (pH 9.3) solution. 
Before sample analysis a solution was prepared with 
1 mL of stock solution with 2 mL of sodium tetraborate 
0.1 M. The pre column derivatization was completed by 
reacting 100 µL of this solution with 50 µL of amino acid 
standard solution for exactly 2 minutes before the injec-
tion on analytic column.
An isocratic HPLC system coupled to a fluorescence 
detector, a sample injector of 20 µl for HPLC and a col-
umn RP-18 50×4.6 mm were utilized (Chromolith Speed-
ROD, Merch, Darmstadt). The mobile phase consisted of 
sodium phosphate buffer 0.05 M (pH 5.95) with methanol 
11.5%. The flow rate was 3.5 ml/minute, detection with 
excitation of 348 nm and emission of 460 nm in the flu-
orescence detector were employed. For standard chro-
matogram amino acid of known concentration were as-
sayed and the retention time of each amino acid was ver-
ified for no overlapping after sample delivery.
Nissl staining and immuno-histochemistry 
Brain tissues removed during surgery or autopsy were 
rapidly immersed in buffered (pH=7.4) 1% paraformalde-
hyde, for 24h at 4oC. Collected hippocampi were sliced in 
0.5 cm sections through longitudinal axis. All tissues were 
then dehydrated by an ethanol series, followed by xylol 
(100%) before inclusion in paraffin. The paraffin included 
tissue was sliced (3 μm) in microtome (Leica) and kept in 
silane-covered slides. After paraffin removal (n=3), sec-
tions from the hippocampus were submitted to the classi-
cal Nissl staining (NS). Cresyl-violet staining was done to 
assess the specimen orientation and to check the localiza-
tion and the extent of the lesion, being possible the classi-
fication of the sclerosis types as described by Blumcke17. 
In summary, five distinct pathological patterns were rec-
ognized after histological analysis: no MTS=“no hippo-
campal cell loss , MTS type 1a=classic hippocampal scle-
rosis , MTS type 1b=severe hippocampal sclerosis , MTS 
type 2=CA1 sclerosis, and MTS type 3=end folium scle-
rosis. Adjacent sections were selected for immuno-his-
tochemistry (n=3).
Paraffin was removed from slices using 100% xylol and 
endogenous peroxidases were blocked with 3% H2O2, for 
15 min. After this procedure, the slices were submitted 
to 10 min of heating in microwave oven. Tissues were 
blocked using 5% bovine albumin during 90 min and in-
cubated in humid chamber with primary monoclonal an-
ti-human IL1β, TNFα (1:50) (BD Bioscience, Minneap-
olis, USA) and CD45 (1:500) (DAKO clone PD7/26) an-
tibodies for 48 hours in the presence of 1% milk. Follow-
ing three washes in PBS, the sections were incubated with 
the secondary antibody (anti-mouse (1:500) from Calbio-
chem, Merck KGaA, Darmstadt, Germany). Immunode-
tection was performed using the Vectastain ABC Elite Kit 
(Vector Burlingame, CA, USA) and the complex antigen-
antibody was visualized using diaminobenzidine in PBS 
and H2O2 (1 µL/mL). Tissue sections were mounted on 
glass slides and the material was examined with a micro-
scope using bright-field illumination. 
Quantification of IL1β and TNFα 
Tissues were homogenized in 0.01M tris-HCl pH 7.6, 
0.001M EDTA, nonidet P-40) 10% glycerol, 0.1M NaCl 
buffer, containing a cocktail of protease inhibitors (Sig-
ma Aldrich Corporation, St Louis, USA). The tissues were 
homogenized by ultrasound (Virsonic 60, Virtis) and 
stored at –80oC until assay. Total protein was quantified 
using method described by Lowry19. A standard curve of 
both cytokines was done to find the liner range of Elisa 
(BD Bioscience OprEITM) method. After this procedure, 
different amount of cerebral tissues were assayed and 80 
pg/ml of protein from all sample homogenates were used 
due to its inclusion in liner range of the method. All as-
says were done in duplicate. The assays were done accord-
ing to method described by manufacturer Kits (Human IL 
– 1 ELISA Kit BD OpteiaTM e Human TNF ELISA Kit BD 
OpteiaTM). The optical density was measure at 450 nm in 
an Elisa reader equipment µQuant Biotek (USA) and af-
ter using the software GEN 5 the concentration of IL1β 
and TNFα in each sample was determined. The concen-
trations were expressed in pg/mg protein. 
Nitric oxide quantification
After tissue removal all hipocampi (control and epi-
leptic) were separated and frozen in liquid nitrogen in less 
of 20 seconds. The samples were homogenized in Tris-
HCl buffer containing 0.2M of KCl being submitted to a 
centrifugation at 10 000g during 10 min at 4oC. To 1 mL 
of supernatant were added 2 ml of NaOH 0.5M and 2 
mL of ZnSO4 10%. This mixture was homogenized dur-
ing 30s and stayed at room temperature during 15 min. A 
new centrifugation was done at 10 000g during 10 min e 
the NO concentration in each sample was quantified us-
ing Nitric Oxide Analyzer (NOATM 280, Sievers Instru-
ments, Inc, Boulder, CO, USA) by chemiluminescence as 
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described20. This method is highly sensitive and 1 pMol 
can be detected. The concentrations in all samples were 
expressed as µMol/mg wet tissue.
Statistical analysis
To compare IL1β, TNFα and glutamate concentra-
tion between epileptic and control groups Student t test 
was employed. To analyze the existence of correlation 
between two different variables the linear correlation of 
Pearson was employed. For this purpose the software Sta-
tistical Package for Social Sciences (SPSS) version 11.0 
for Windows was used. A p<0.05 value was accepted as 
significant.
RESULTS
The Table summarizes all clinical data concerning to 
patients submitted to cortico-amygdalo-hippocampecto-
my at the Hospital São Paulo (UNIPETE/SPDM) including 
sex, age at surgery, presence of initial event, duration of 
epilepsy, brain side involved, presence of hyperintense sig-
nal in temporal pole structures, Engel’s scale after surgery 
and type of sclerosis, according to Blumcke classification17. 
In this context, the Engel’s distribution between pa-
tients was 55.2% as IA, 10.3% as IB, 24.1% as IIIA, 3.4% as 
IVA, 3.6% as IIIB and 3.4 as IVC showing that a great ma-
jority of patients presented improvement in their quality 
of life after surgery, due to minor seizure episodes. 
Table. Clinical data of patients submitted to cortico-amygdalo-hippocampectomy.
No Sex Age Initial event Age of begin
Duration/
years Side
Temporal pólo 
hypersignal Engel scale
Sclerosis 
type
1 F 38 + 10 28 L – IB –
2 M 39 + 7 32 L + IA –
3 F 38 + 26 12 L + IA –
4 M 28 – 25 3 L – IIIA IA
5 F 38 – 7 31 L + IA IB
6 M 28 + 14 14 R – IA IB
7 F 29 + 24 5 L – IA IB
8 F 31 + 15 16 R – IVA –
9 F 19 – 8 11 L + IA IA
10 F 20 – 15 5 L – IIIA AT
11 M 39 – 15 14 L + IA IB
12 F 39 – 22 17 L – IA AT
13 M 41 + 23 18 R – IVC IB
14 M 46 + 12 34 L – IIIA IB
15 F 30 – 5 25 L + IIIB IA
16 M 38 – 33 5 R – IIIA –
17 M 32 – 7 25 L – IB IA
18 F 26 – 21 5 L – IA –
19 F 30 – 8 22 R + IIIA IA
20 F 41 – 1,5 40 L – IA IA
21 F 39 – 26 13 L – IIIA AT
22 F 51 + 16 35 L – IA –
23 F 35 + 7 28 R – IA –
24 F 31 + 0.8 30 R – IA IB
25 F 48 – 6 42 L – IA –
26 F 56 – 27 29 L – IIIA AT
27 F 44 – 13 31 L – IB –
28 F 46 – 23 23 L – IA IA
29 F 49 – 7 42 R + IA –
M: male; F: female; Age: at surgery intervention; Initial event: presence of febrile seizures or status epilepticus; Durantion: duration of epilepsy in years; Side: 
side with major involvement; Engel scale: Engel classification after surgery and sclerosis types: according to (8) classification; IA: type IA; IB: type IB; AT: atypical 
hippocampal sclerosis.
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After Nissl staining, the types of hippocampal sclero-
sis were identified as shown in Fig 1, panel A, B, C and D. 
The Fig 1A and B shows the stained tissue from patients 
presenting HS type 1B. Fig 1 C shows an atypical HS (AT) 
and in the Fig 1D we can visualize an unclassified HS due 
to damage of the tissue during surgery.
The quantification of IL1β by ELISA method in scle-
rotic and autopsy/control hippocampi showed values of 
117.6±15.4 and 92.3±28.8 pg/mg protein (p=0.023) re-
Fig 1. Hippocampal sclerosis. Nissl staining
of hippocampus of patients with TLE and HS 
[A] Patient number 5 with HS Type 1B (scale 
bar 1000 μm). [B] Patient number 13, HS 
Type 1B (scale bar 1000 μm; Cresil). [C] Pa-
tient number 12, atypical HS; [D] HS without 
classification.
Fig 2. Immunohistochemistry (IL1β). IL1β immunohistochemistry 
of patients 5 and 9 and autopsy/control tissue. [A] Patient num-
ber 9, CA2-CA3 regions (scale bar 100 μm). [B] Patient number 5, 
CA2- CA3 regions (scale bar 100 μm; [C] Autopsy/control tissue 
CA2- CA3 regions (scale bar 100 μm; IL1-β).
spectively. The levels of TNFα obtained in both groups 
were 28.9±14.5 (sclerotic hippocampi) and 17.8±16 pg/
mg protein (autopsy/control tissue) (p=0.049), showing 
increased concentration of both cytokines in the hippo-
campi of patients with TLE. These findings could be visu-
alized and confirmed, in part, through the immuno-his-
tochemistry analysis of IL1β. The immuno-histochem-
istry done against IL1β in autopsy/control and sclerotic 
hippocampus is shown in Fig 2. The panels A and B show 
Arq Neuropsiquiatr 2011;69(1)
 97
FLAIR: temporal epilepsy 
Varella et al.
CA2 and CA3 regions from the hippocampus of two dif-
ferent patients. Panel C shows an autopsy/control tissue 
submitted to the same staining procedure. As can be vi-
sualized, there is an increased expression of IL1β in HS, 
when compared with the same regions of autopsy/con-
trol tissue. Immuno-histochemistry done with TNFα did 
not show difference between autopsy/control and sclerot-
ic hippocampus (data not shown).
The amino acids levels in sclerotic and autopsy/con-
trol tissues demonstrated decreased concentration of glu-
tamate in patients (4.76±1.17 ng/mg wet tissue), when 
compared with autopsy/control tissues (6.31±0.83 ng/mg 
wet tissue, p=0.00051). 
A presence of perivascular lymphocytes infiltrate 
could also be identified in Fig 3, when the tissues were 
submitted to immunostaining against CD45 antibody. 
This infiltrate could not be visualized in autopsy/control 
tissues.
A positive correlation was found between the level 
of IL1β and the signal presented in the tail of hippocam-
pus as shown in Fig 4 (top panel) (p=0.033, Pearson co-
efficient=0.436). In contrast, a negative correlation was 
found between glutamate levels and FLAIR MRI signal 
intensity in hippocampal tail (p=0.025, Pearson coeffi-
cient=0.457) as shown in Fig 4 (lower panel). 
No relationship between the levels of TNFα and 
FLAIR MRI signal intensity in head, body and tail of the 
hippocampus of patients with TLE was found, showing 
no association between these variables (data not shown). 
In addition, a positive correlation was found analyzing 
NO concentration and the FLAIR MRI signal intensity 
in the head (Pearson coefficient=0.498, p=0.013); body 
(Pearson coefficient=0.505, p=0.012) and tail of the hip-
pocampus of patients with epilepsy (Pearson coefficient= 
0.532, p=0.007) (Fig 5).
DISCUSSION
The present work showed changes in the concentra-
tion of different inflammatory mediators such as IL1β and 
TNFα in the hippocampus of patients with MTS. In addi-
tion, a decreased glutamate concentration was also found, 
when compared with autopsy/control tissues. The mea-
Fig 3. Imminohistochemistry (CD45). [A] Immunohistochemistry 
against CD45 showing lymphocytes in peri-vascular fashion (scale 
bar 50 μm, CD45). [B] CD-45 amplification (scale bar 10 μm).
Fig 4. Correlation between Hippocampal FLAIR signal and IL1β 
and glutamate concentrations. [A] Hippocampal FLAIR signal ver-
sus IL1β concentration. [B] Hippocampal FLAIR signal versus glu-
tamate concentration.
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surement of cytokines NO and glutamate was done in 
the head of the hippocampus since Bernasconi et al.8 de-
scribed this region as that responsible for the major sig-
nal alteration on MRI. We also found a linear relation-
ship between cytokines and NO levels with the signal on 
FLAIR MRI in head, body and tail of the hippocampus. 
These data suggest the presence of an inflammatory 
process in the hippocampus, associated with increased 
release of glutamate, which is indicative of a persistent 
excitotoxicity. Our data are supported by previous re-
port21, which demonstrated increased extracellular gluta-
mate levels (increased release), using microdialysis probes 
in humans with TLE. A deficiency in glutamine synthe-
sis in astrocytes, found by several authors22, can also ex-
plain the high levels of glutamate in extracellular space, 
suggesting increased release of this amino acid. Working 
with synaptosomes from hippocampus of patients with 
TLE and MTS, was found23 increased basal release of glu-
tamate and GABA, data that could support our findings. 
Thus, the decreased concentration found in sclerotic hip-
pocampus could be associated to increased release of this 
neurotransmitter, as already reported by several authors. 
Cytokines, a diverse group of polypeptides that are 
generally associated with inflammation, immune activa-
tion, cell differentiation or death include interleukins, in-
terferons, tumor necrosis factors, chemokines and growth 
factors24. Cytokines can exert direct action on neurons, 
indirect action via glial cell, direct action on brain vas-
culature and on physiological parameters such as re-
gional blood flow and temperature. IL1 β and TNFα act 
on distinct cell-surface receptors but share some com-
mon signaling mechanisms related to neurodegenera-
tion. IL1 β can induces cell death11, as well as cyclooxy-
genase 2 (COX2) and oxide nitric synthase overexpres-
sion (iNOS)24. In addition, seizures stimulate increase 
in the levels of IL1α, IL1β, IL6 and TNFα in the brain25. 
The mechanism by which IL1 affect seizure activity is not 
known, but Allan26 showed that the association between 
administration of AMPA receptor agonist and IL1 pro-
duce widespread cortical cell death. This fact is not ob-
served when AMPA or IL1 are administered alone26. This 
fact indeed support the hypothesis that suggest the par-
ticipation of increased release of glutamate associated 
with the increased levels of cytokines, in the process of 
cell death, observed in the hippocampus of patients with 
TLE and MTS. Glutamate during excitotoxic phenom-
enon stimulates AMPA and NMDA receptors produc-
ing excessive depolarization of postsynaptic membrane, 
which results in an osmotic imbalance when countered 
by an influx of Na+, Cl– and water12. 
Glial cells can also secrete IL1β and TNFα, which in 
turn, can act on these cells in an autocrine manner. IL1β 
and TNFα induce the proliferation of astrocytes, a pro-
cess known as astrogliosis11, which is also found in hip-
pocampal sclerosis6. 
The NO level from sclerotic hippocampus was corre-
lated with FLAIR hyperintense signal in the head, body 
and tail of this structure, supporting the hypothesis of 
participation of NO production in the hippocampal scle-
rosis. Neuronal NOS is localized in the hypothalamic su-
praoptic and paraventricular nuclei, both of which are 
mainly involved in the neurosecretory activity of this 
Fig 5. Hippocampal FLAIR signal and NO concentration. [A] FLAIR 
signal from hippocampal head versus NO concentration. [B] FLAIR 
signal from hippocampal body versus NO concentration. [C] FLAIR 
signal from hippocampal tail versus NO concentration.
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area. NO is able to interact with many intracellular targets 
to trigger an array of signal transduction pathways, result-
ing in stimulatory or inhibitory output signals. However, 
it becomes noxious if it is produced in excess27. Recently 
the term “nitrosative stress” has been used to indicate the 
cellular damage that is elicited by excess of NO and reac-
tive nitrogen species28. In addition, NO has been shown 
to stimulate the release of noradrenaline and glutamate in 
the hippocampus29. This data can support our hypothesis 
concerning to increased release of this neurotransmitter 
since we found low levels of glutamate in sclerotic tissues, 
when compared with autopsy/control tissues. Taken to-
gether, these data support the idea that the hyperintense 
signal on FLAIR MRI could be the result of increased ex-
pression of cytokines and NO associated with increased 
excitotoxicity in TLE.
The correlation between ipsilateral versus contralat-
eral signals showed that although the hyperintense sig-
nal was major in the sclerotic side the contralateral hip-
pocampus is frequently involved since it also presented 
increased FLAIR signal.
As lymphocytes were also visualized in epileptic tissue 
we can suppose that both humoral and cellular immune 
systems are activated in TLE associated with HS. This data 
were previously reported by other authors9,30-32, who dem-
onstrate the presence of cytokines, complement activation 
as well and NO release in the blood after an ictal event. 
Taken together, these data show the participation of 
markers of inflammatory process in the physiopathology 
and in FLAIR signal related to temporal lobe epilepsy, as-
sociated to hippocampal sclerosis.
The authors thank to Hilda Reis and Margaret Gori 
Mouro for their technical assistance as well as all clini-
cians involved in the treatment of the patients. 
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